Hoda Yeganehjoo, Ph.D.

 Featured Publications

The stimulatory impact of d-d-Tocotrienol on the differentiation of murine MC3T3-E1 preosteoblasts.

Shah AK, Yeganehjoo H, Mol. Cell. Biochem. 2019 Oct

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.

Mo H, Jeter R, Bachmann A, Yount ST, Shen CL, Yeganehjoo H Front Pharmacol 2018 9 1515

Synergistic Impact of d-d-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells.

Yeganehjoo H, DeBose-Boyd R, McFarlin BK, Mo H Nutr Cancer 2017 Mar 1-10

Peroxisome proliferator-activated receptor ? down-regulation mediates the inhibitory effect of d-d-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.

Torabi S, Yeganehjoo H, Shen CL, Mo H Nutr Res 2016 Nov

Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase.

Fernandes NV, Yeganehjoo H, Katuru R, DeBose-Boyd RA, Morris LL, Michon R, Yu ZL, Mo H Exp. Biol. Med. (Maywood) 2013 Nov 238 11 1265-74

?-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells.

Jones S, Fernandes NV, Yeganehjoo H, Katuru R, Qu H, Yu Z, Mo H Nutr Cancer 2013 65 4 600-10

Mevalonate-suppressive dietary isoprenoids for bone health.

Mo H, Yeganehjoo H, Shah A, Mo WK, Soelaiman IN, Shen CL J. Nutr. Biochem. 2012 Dec 23 12 1543-51